Publications by authors named "Linxia Jiang"

Claim this Profile
E
Enhanced Tumor Immunotherapy by Triple Amplification Effects of Nanomedicine on the STING Signaling Pathway in Dendritic Cells.
Xiang-Yu Wang, Yi Yan, Xiao-Ru Guo, An Lu, Lin-Xia Jiang

Adv Healthc Mater· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double Braking Effects of Nanomedicine on Mitochondrial Permeability Transition Pore for Treating Idiopathic Pulmonary Fibrosis.
An Lu, Zhiyi Xu, Zhixia Zhao, Yi Yan, Linxia Jiang

Adv Sci (Weinh)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment.
Shi-He Cui, Yi Yan, An Lu, Yun Dou, Zhen-Wen Li, Lin-Xia Jiang, Dong Jiang

ACS Nano· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritis.
Yi Yan, An Lu, Yun Dou, Zhen Zhang, Xiang-Yu Wang, Lin-Xia Jiang, Dong Jiang

Adv Sci (Weinh)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation of L-arginine-modified liposomes targeting M1 macrophages to enhance curcumin therapeutic efficacy in ALI.
Linxia Jiang, Pengchuan Guo, Jiarui Ju, Xiaoyan Zhu, Shiyue Wu

Eur J Pharm Biopharm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ionic Liquids: Promising Approach for Oral Drug Delivery.
Linxia Jiang, Yi Sun, An Lu, Xiangyu Wang, Yujie Shi

Pharm Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-viral vectors for RNA delivery.
Yi Yan, Xiao-Yu Liu, An Lu, Xiang-Yu Wang, Lin-Xia Jiang

J Control Release· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dry powder inhalable formulation of salvianolic acids for the treatment of pulmonary fibrosis: safety, lung deposition, and pharmacokinetic study.
Linxia Jiang, Yijun Li, Jiaqi Yu, Jianhong Wang, Jiarui Ju

Drug Deliv Transl Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process.
Linxia Jiang, Jianhong Wang, Jiarui Ju, Jundong Dai

Eur J Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.
Jiaqi Yu, Hao Chen, Linxia Jiang, Jianhong Wang, Jundong Dai

J Pharm Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis